OS Therapies, Inc. (OSTX)
1.00
+0.02
(+2.03%)
USD |
NYAM |
Nov 06, 16:00
0.9355
-0.06
(-6.45%)
After-Hours: 20:00
OS Therapies Market Cap : 45.28M for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 06, 2026 | 45.28M |
| November 05, 2026 | 44.38M |
| November 04, 2026 | 52.08M |
| November 03, 2026 | 52.53M |
| November 02, 2026 | 52.08M |
| October 30, 2026 | 56.15M |
| October 29, 2026 | 58.87M |
| October 28, 2026 | 56.60M |
| October 27, 2026 | 55.70M |
| October 26, 2026 | 54.79M |
| October 23, 2026 | 56.60M |
| October 22, 2026 | 56.60M |
| October 21, 2026 | 57.51M |
| October 20, 2026 | 57.06M |
| October 19, 2026 | 57.51M |
| October 16, 2026 | 59.77M |
| October 15, 2026 | 63.85M |
| October 14, 2026 | 62.94M |
| October 13, 2026 | 65.66M |
| October 12, 2026 | 70.64M |
| October 09, 2026 | 73.36M |
| October 08, 2026 | 73.36M |
| October 07, 2026 | 70.19M |
| October 06, 2026 | 67.47M |
| October 05, 2026 | 72.45M |
| Date | Value |
|---|---|
| October 02, 2026 | 73.36M |
| October 01, 2026 | 72.91M |
| September 30, 2026 | 72.45M |
| September 29, 2026 | 72.91M |
| September 28, 2026 | 74.72M |
| September 25, 2026 | 75.17M |
| September 24, 2026 | 75.17M |
| September 23, 2026 | 74.72M |
| September 22, 2026 | 80.15M |
| September 21, 2026 | 78.79M |
| September 18, 2026 | 80.15M |
| September 17, 2026 | 82.87M |
| September 16, 2026 | 79.25M |
| September 15, 2026 | 80.60M |
| September 14, 2026 | 76.98M |
| September 11, 2026 | 76.08M |
| September 10, 2026 | 82.42M |
| September 09, 2026 | 84.23M |
| September 08, 2026 | 82.87M |
| September 04, 2026 | 85.13M |
| September 03, 2026 | 82.42M |
| September 02, 2026 | 77.43M |
| September 01, 2026 | 75.17M |
| August 31, 2026 | 76.53M |
| August 28, 2026 | 74.26M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.654B |
| Alnylam Pharmaceuticals, Inc. | 20.88B |
| Anika Therapeutics, Inc. | 194.72M |
| Savara, Inc. | 992.08M |
| Vericel Corp. | 2.795B |
Market Cap Related Metrics
| PEG Ratio | -0.0286 |
| Price | 1.00 |
| Earnings Yield | -104.3% |
| PEGY Ratio | -0.0286 |